NNVC Company Profile and Key Details

Q: Who are the executives of NNVC?

Dr. Anil R. Diwan Ph.D.Executive Chairman, Pres, Chief Executive Officer & Sec.Ms. Meeta R. Vyas B.S., M.B.A., SB, MBAChief Financial OfficerDr. Randall W. Barton Ph.D.Chief Scientific Officer & Chief Regulatory Officer

AMEX : NNVC

NanoViricides

$1.13

0.03+2.73%

At Close 4:00 PM

63.88

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NanoViricides, Inc. (NNVC) stock surged +2.73%, trading at $1.13 on AMEX, up from the previous close of $1.10. The stock opened at $1.12, fluctuating between $1.10 and $1.13 in the recent session.

Stock Snapshot

1.1

Prev. Close

20.19M

Market Cap

1.1

Day Low

-2.26

P/E Ratio

-0.5

EPS (TTM)

-0.53

Cash Flow per Share

1.12

Open

17.87M

Number of Shares

1.13

Day High

96.47%

Free Float in %

1.06

Book Value

251K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 31, 2025	1.12	1.13	1.10	1.13	263.62K
Dec 30, 2025	1.14	1.16	1.10	1.10	298.86K
Dec 29, 2025	1.17	1.19	1.12	1.12	312.89K
Dec 26, 2025	1.17	1.20	1.15	1.19	266.68K
Dec 24, 2025	1.20	1.22	1.17	1.19	148.46K
Dec 23, 2025	1.25	1.27	1.20	1.20	149.84K
Dec 22, 2025	1.25	1.28	1.22	1.25	183.18K
Dec 19, 2025	1.20	1.31	1.20	1.24	358.84K
Dec 17, 2025	1.35	1.35	1.24	1.24	246.43K
Dec 16, 2025	1.27	1.39	1.27	1.29	388.42K
Dec 15, 2025	1.29	1.29	1.23	1.23	287.12K
Dec 12, 2025	1.30	1.30	1.25	1.25	313.59K
Dec 11, 2025	1.35	1.35	1.27	1.30	294.52K
Dec 10, 2025	1.37	1.40	1.28	1.32	271.12K
Dec 09, 2025	1.47	1.49	1.33	1.37	474.93K
Dec 08, 2025	1.25	1.49	1.23	1.43	1.08M
Dec 05, 2025	1.24	1.28	1.23	1.23	337.22K
Dec 04, 2025	1.11	1.25	1.10	1.22	328.33K
Dec 03, 2025	1.09	1.11	1.07	1.11	245.71K
Dec 02, 2025	1.14	1.19	1.09	1.09	388.13K

Contact Details

Shelton, CT 06484

United States

https://www.nanoviricides.com 203 937 6137

About Company

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Stock Peers

TBXU

0.0651+0.21%

Direxion Shares ETF Trust$31.23 PTN

0.89+6.14%

Palatin Technologies, Inc.$15.38 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 NSRX

1.36+17.46%

Nasus Pharma Ltd.$9.15 CYBN

-0.39-4.55%

Cybin Inc.$8.18 ARMP

0.04+0.64%

Armata Pharmaceuticals, Inc.$6.28 NBY

-0.555-8.96%

NovaBay Pharmaceuticals, Inc.$5.64 CVM

0.03+0.57%

CEL-SCI Corporation$5.26 PHGE

0.01+0.54%

BiomX Inc.$1.87 PLX

0.05500003+3.15%

Protalix BioTherapeutics, Inc.$1.80

Frequently Asked Questions

What is the current NanoViricides, Inc. (NNVC) stock price?

NanoViricides, Inc. (AMEX: NNVC) stock price is $1.13 in the last trading session. During the trading session, NNVC stock reached the peak price of $1.13 while $1.10 was the lowest point it dropped to. The percentage change in NNVC stock occurred in the recent session was 2.73% while the dollar amount for the price change in NNVC stock was $0.03.

NNVC's industry and sector of operation?

The AMEX listed NNVC is part of Biotechnology industry that operates in the broader Healthcare sector. NanoViricides, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NNVC?

Dr. Anil R. Diwan Ph.D.
Executive Chairman, Pres, Chief Executive Officer & Sec.
Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA
Chief Financial Officer
Dr. Randall W. Barton Ph.D.
Chief Scientific Officer & Chief Regulatory Officer

How NNVC did perform over past 52-week?

NNVC's closing price is 20.21% higher than its 52-week low of $0.94 where as its distance from 52-week high of $2.23 is -49.33%.

How many employees does NNVC have?

Number of NNVC employees currently stands at 7.

Link for NNVC official website?

Official Website of NNVC is: https://www.nanoviricides.com

How do I contact NNVC?

NNVC could be contacted at phone 203 937 6137 and can also be accessed through its website. NNVC operates from 1 Controls Drive, Shelton, CT 06484, United States.

How many shares of NNVC are traded daily?

NNVC stock volume for the day was 251K shares. The average number of NNVC shares traded daily for last 3 months was 343.75K.

What is the market cap of NNVC currently?

The market value of NNVC currently stands at $20.19M with its latest stock price at $1.13 and 17.87M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7
Beta	1.16
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	7
Beta	1.16
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

NNVC Company Profile and Key Details

NanoViricides

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Valuation Metrics

Shareholding & Insider Activity

Key Takeaways

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Price Forecast & Outlook